Borlaug BA, Sharma K, Shah SJ, Ho JE (2023) Heart failure with preserved ejection fraction: JACC scientific statement. J Am Coll Cardiol 81(18):1810–1834. https://doi.org/10.1016/j.jacc.2023.01.049
Shah SJ, Kitzman DW, Borlaug BA et al (2016) Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap. Circulation 134(1):73–90. https://doi.org/10.1161/circulationaha.116.021884
Article PubMed PubMed Central Google Scholar
Sotomi Y, Hikoso S, Nakatani D et al (2021) Sex differences in heart failure with preserved ejection fraction. J Am Heart Assoc 10(5):e018574. https://doi.org/10.1161/jaha.120.018574
Article CAS PubMed PubMed Central Google Scholar
Smereka Y, Ezekowitz JA (2024) HFpEF and sex: understanding the role of sex differences. Can J Physiol Pharmacol 102(8):465–475. https://doi.org/10.1139/cjpp-2023-0403
Article CAS PubMed Google Scholar
Beale AL, Meyer P, Marwick TH, Lam CSP, Kaye DM (2018) Sex differences in cardiovascular pathophysiology: why women are overrepresented in heart failure with preserved ejection fraction. Circulation 138(2):198–205. https://doi.org/10.1161/circulationaha.118.034271
Sabbatini AR, Kararigas G (2020) Menopause-related estrogen decrease and the pathogenesis of HFpEF: JACC review topic of the week. J Am Coll Cardiol 75(9):1074–1082. https://doi.org/10.1016/j.jacc.2019.12.049
Article CAS PubMed Google Scholar
Lee SU, Park JY, Hong S et al (2024) Risk factors for pregnancy-associated heart failure with preserved ejection fraction and adverse pregnancy outcomes: a cross-sectional study. BMC Pregnancy Childbirth 24(1):211. https://doi.org/10.1186/s12884-024-06402-5
Article PubMed PubMed Central Google Scholar
Briller JE, Mogos MF, Muchira JM, Piano MR (2021) Pregnancy associated heart failure with preserved ejection fraction: risk factors and maternal morbidity. J Card Fail 27(2):143–152. https://doi.org/10.1016/j.cardfail.2020.12.020
Tibrewala A, Yancy CW (2019) Heart failure with preserved ejection fraction in women. Heart Fail Clin 15(1):9–18. https://doi.org/10.1016/j.hfc.2018.08.002
Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. New Engl J Med 355(3):251–259. https://doi.org/10.1056/NEJMoa052256
Article CAS PubMed Google Scholar
Redfield MM, Borlaug BA (2023) Heart failure with preserved ejection fraction: a review. JAMA 329(10):827–838. https://doi.org/10.1001/jama.2023.2020
Pepine CJ, Merz CNB, El Hajj S et al (2020) Heart failure with preserved ejection fraction: similarities and differences between women and men. Int J Cardiol 304:101–108. https://doi.org/10.1016/j.ijcard.2020.01.003
Pandey A, Omar W, Ayers C et al (2018) Sex and race differences in lifetime risk of heart failure with preserved ejection fraction and heart failure with reduced ejection fraction. Circulation 137(17):1814-1823. https://doi.org/10.1161/circulationaha.117.031622
Toth PP, Gauthier D (2021) Heart failure with preserved ejection fraction: disease burden for patients, caregivers, and the health-care system. Postgrad Med 133(2):140–145. https://doi.org/10.1080/00325481.2020.1842621
Dewan P, Rørth R, Raparelli V et al (2019) Sex-related differences in heart failure with preserved ejection fraction. Circ Heart Fail 12(12):e006539. https://doi.org/10.1161/circheartfailure.119.006539
Deswal A, Bozkurt B (2006) Comparison of morbidity in women versus men with heart failure and preserved ejection fraction. Am J Cardiol 97(8):1228–1231. https://doi.org/10.1016/j.amjcard.2005.11.042
Lam CS, Carson PE, Anand IS et al (2012) Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in heart failure with preserved ejection fraction (I-PRESERVE) trial. Circ Heart Fail 5(5):571–578. https://doi.org/10.1161/circheartfailure.112.970061
Article CAS PubMed PubMed Central Google Scholar
O'Neal WT, Sandesara P, Hammadah M et al (2017) Gender differences in the risk of adverse outcomes in patients with atrial fibrillation and heart failure with preserved ejection fraction. Am J Cardiol 119(11):1785–1790. https://doi.org/10.1016/j.amjcard.2017.02.045
Article PubMed PubMed Central Google Scholar
Eaton CB, Pettinger M, Rossouw J et al (2016) Risk factors for incident hospitalized heart failure with preserved versus reduced ejection fraction in a multiracial cohort of postmenopausal women. Circ Heart Fail 9(10). https://doi.org/10.1161/circheartfailure.115.002883
Chang PP, Wruck LM, Shahar E et al (2018) Trends in hospitalizations and survival of acute decompensated heart failure in four US communities (2005-2014): ARIC study community surveillance. Circulation 138(1):12–24. https://doi.org/10.1161/circulationaha.117.027551
Article PubMed PubMed Central Google Scholar
Upadhya B, Kitzman DW (2020) Heart failure with preserved ejection fraction: new approaches to diagnosis and management. Clin Cardiol 43(2):145–155. https://doi.org/10.1002/clc.23321
Lee DS, Gona P, Albano I et al (2011) A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction. Circ Heart Fail 4(1):36–43. https://doi.org/10.1161/circheartfailure.110.957480
Goyal P, Paul T, Almarzooq ZI et al (2017) Sex- and race-related differences in characteristics and outcomes of hospitalizations for heart failure with preserved ejection fraction. J Am Heart Assoc 6(4). https://doi.org/10.1161/jaha.116.003330
Duca F, Zotter-Tufaro C, Kammerlander AA et al (2018) Gender-related differences in heart failure with preserved ejection fraction. Sci Rep 8(1):1080. https://doi.org/10.1038/s41598-018-19507-7
Article CAS PubMed PubMed Central Google Scholar
Pagel PS, Tawil JN, Boettcher BT et al (2021) Heart failure with preserved ejection fraction: a comprehensive review and update of diagnosis, pathophysiology, treatment, and perioperative implications. J Cardiothorac Vasc Anesth 35(6):1839–1859. https://doi.org/10.1053/j.jvca.2020.07.016
Gorter TM, van Veldhuisen DJ, Bauersachs J et al (2018) Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 20(1):16–37. https://doi.org/10.1002/ejhf.1029
Melenovsky V, Hwang SJ, Lin G, Redfield MM, Borlaug BA (2014) Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J 35(48):3452–3462. https://doi.org/10.1093/eurheartj/ehu193
Article CAS PubMed PubMed Central Google Scholar
Inciardi RM, Abanda M, Shah AM et al (2023) Right ventricular function and pulmonary coupling in patients with heart failure and preserved ejection fraction. J Am Coll Cardiol 82(6):489–499. https://doi.org/10.1016/j.jacc.2023.05.010
Carbone S, Popovic D, Lavie CJ, Arena R (2017) Obesity, body composition and cardiorespiratory fitness in heart failure with preserved ejection fraction. Future Cardiol 13(5):451–463. https://doi.org/10.2217/fca-2017-0023
Article CAS PubMed Google Scholar
Dhakal BP, Malhotra R, Murphy RM et al (2015) Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction. Circ Heart Fail 8(2):286–294. https://doi.org/10.1161/circheartfailure.114.001825
Faxén UL, Hage C, Donal E, Daubert JC, Linde C, Lund LH (2018) Patient reported outcome in HFpEF: sex-specific differences in quality of life and association with outcome. Int J Cardiol 267:128–132. https://doi.org/10.1016/j.ijcard.2018.04.102
Honigberg MC, Lau ES, Jones AD et al (2020) Sex differences in exercise capacity and quality of life in heart failure with preserved ejection fraction: a secondary analysis of the RELAX and NEAT-HFpEF trials. J Cardiac Fail 26(3):276–280. https://doi.org/10.1016/j.cardfail.2020.01.001
Comments (0)